We are presenting exciting progress about MTHFD1/2 inhibitors at BIO International in Boston

by admin
maj 25, 2023

You can listen to our company presentation on Monday, June 5 and during the 12th International Cancer Cluster Showcase satellite symposium at BIO.

Rekommenderade artiklar

One-carbon Therapeutics announces oversubscribed private placement financing of SEK 153 million (€13.9 million)

Solna, Sweden, December 1, 2025. One-carbon Therapeutics AB, a clinical-stage

One-carbon Therapeutics AB Announces First Subject Dosed in the ODIN Phase 1/2 Clinical Study of TH9619 in Advanced Solid Tumors

Stockholm, Sweden. November 17th, 2025. One-carbon Therapeutics AB, a clinical-stage biotechnology

One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe

One-carbon therapeutics AB is discussing the ODIN trial with several